Beneficient Form 8-K Summary
Business Context and Reporting Period
Beneficient filed a Form 8-K dated January 31, 2024, with the report signed and filed on February 6, 2024. The filing concerns the creation of Series B-2 and Series B-3 Resettable Convertible Preferred Stock and related unregistered issuances. It does not provide quarterly or annual financial results.
Key Financial and Capitalization Matters
- On February 6, 2024, a subsidiary completed a liquidity transaction involving a limited partner interest with a stated net asset value of $2.0 million.
- In exchange for the alternative asset, the customer received 200,000 shares of Series B-2 Preferred Stock.
- Series B-2 shares have an initial conversion price of $0.40 per share, subject to monthly resets and a $0.20 floor. Based on the initial price, the shares could convert into 5.0 million Class A common shares; the filing authorizes a maximum of 10.0 million underlying shares.
- The Company issued 20,000 Series B-3 Preferred shares to a consultant for investor-relations advisory services.
- Series B-3 shares have an initial conversion price of $0.35 per share, subject to monthly resets and a $0.175 floor. Based on the initial price, the shares could convert into approximately 571,429 Class A common shares; the filing authorizes a maximum of 1,142,857 underlying shares.
- Both preferred series rank senior to common stock, pari passu with specified existing preferred series, and junior to Company indebtedness. Each has a $10.00 per-share liquidation preference and receives dividends only if and when dividends are paid on common stock on an as-converted basis.
- The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating-performance metrics for the period.
Material Changes Versus the Prior Comparable Period
- The filing establishes two new preferred-stock series and reports related issuances. It does not provide comparable-period financial statements or quantify changes in operating performance.
- The securities were issued without registration under the Securities Act in reliance on Section 4(a)(2) and Regulation D.
Terms, Outlook, Risks, and Unusual Items
- Both series are optionally convertible upon two business days’ notice. Their conversion prices reset monthly to the five-day trailing volume-weighted average market price, subject to the stated floors and caps.
- Mandatory conversion generally occurs at the earlier of the applicable fifth-anniversary timing, subject to SEC reporting or resale-registration conditions, or the first later date when resale under Rule 144 or an effective resale registration statement becomes available.
- Conversions are subject to a 4.99% beneficial-ownership limitation per holder, which may delay conversion.
- The potential issuance of up to 11,142,857 Class A common shares from the two series, based on the stated maximums, could materially dilute existing common stockholders.
- The filing contains no management guidance, business outlook, or contingency forecast.
Facts Investors Should Verify
- Review Exhibits 3.1 and 3.2 for the complete rights, reset mechanics, conversion limitations, and protective provisions.
- Verify the number of Class A shares outstanding and the potential dilution relative to the maximum shares issuable on conversion.
- Confirm the alternative asset’s valuation, accounting treatment, and whether the $2.0 million net asset value represents consideration recognized by Beneficient.
- Review subsequent filings for actual conversions, monthly conversion-price resets, resale registration, and Rule 144 availability.
- Assess the Company’s existing indebtedness and senior claims, because both preferred series rank junior to debt.